These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 33594256)

  • 21. Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia.
    Kim C; Ho DH; Suk JE; You S; Michael S; Kang J; Joong Lee S; Masliah E; Hwang D; Lee HJ; Lee SJ
    Nat Commun; 2013; 4():1562. PubMed ID: 23463005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced phosphatase activity attenuates α-synucleinopathy in a mouse model.
    Lee KW; Chen W; Junn E; Im JY; Grosso H; Sonsalla PK; Feng X; Ray N; Fernandez JR; Chao Y; Masliah E; Voronkov M; Braithwaite SP; Stock JB; Mouradian MM
    J Neurosci; 2011 May; 31(19):6963-71. PubMed ID: 21562258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alterations in mGluR5 expression and signaling in Lewy body disease and in transgenic models of alpha-synucleinopathy--implications for excitotoxicity.
    Price DL; Rockenstein E; Ubhi K; Phung V; MacLean-Lewis N; Askay D; Cartier A; Spencer B; Patrick C; Desplats P; Ellisman MH; Masliah E
    PLoS One; 2010 Nov; 5(11):e14020. PubMed ID: 21103359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calpain-cleavage of alpha-synuclein: connecting proteolytic processing to disease-linked aggregation.
    Dufty BM; Warner LR; Hou ST; Jiang SX; Gomez-Isla T; Leenhouts KM; Oxford JT; Feany MB; Masliah E; Rohn TT
    Am J Pathol; 2007 May; 170(5):1725-38. PubMed ID: 17456777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein.
    Wang B; Underwood R; Kamath A; Britain C; McFerrin MB; McLean PJ; Volpicelli-Daley LA; Whitaker RH; Placzek WJ; Becker K; Ma J; Yacoubian TA
    J Neurosci; 2018 Sep; 38(38):8211-8232. PubMed ID: 30093536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lewy body-like α-synuclein aggregates resist degradation and impair macroautophagy.
    Tanik SA; Schultheiss CE; Volpicelli-Daley LA; Brunden KR; Lee VM
    J Biol Chem; 2013 May; 288(21):15194-210. PubMed ID: 23532841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MerTK is a mediator of alpha-synuclein fibril uptake by human microglia.
    Dorion MF; Yaqubi M; Senkevich K; Kieran NW; MacDonald A; Chen CXQ; Luo W; Wallis A; Shlaifer I; Hall JA; Dudley RWR; Glass IA; ; Stratton JA; Fon EA; Bartels T; Antel JP; Gan-Or Z; Durcan TM; Healy LM
    Brain; 2024 Feb; 147(2):427-443. PubMed ID: 37671615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ESCRT-mediated uptake and degradation of brain-targeted α-synuclein single chain antibody attenuates neuronal degeneration in vivo.
    Spencer B; Emadi S; Desplats P; Eleuteri S; Michael S; Kosberg K; Shen J; Rockenstein E; Patrick C; Adame A; Gonzalez T; Sierks M; Masliah E
    Mol Ther; 2014 Oct; 22(10):1753-67. PubMed ID: 25008355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The involvement of α-synucleinopathy in the disruption of microglial homeostasis contributes to the pathogenesis of Parkinson's disease.
    Miao Y; Meng H
    Cell Commun Signal; 2024 Jan; 22(1):31. PubMed ID: 38216911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurons and Glia Interplay in α-Synucleinopathies.
    Mavroeidi P; Xilouri M
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody-aided clearance of extracellular α-synuclein prevents cell-to-cell aggregate transmission.
    Bae EJ; Lee HJ; Rockenstein E; Ho DH; Park EB; Yang NY; Desplats P; Masliah E; Lee SJ
    J Neurosci; 2012 Sep; 32(39):13454-69. PubMed ID: 23015436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunotherapy with an antibody against CD1d modulates neuroinflammation in an α-synuclein transgenic model of Lewy body like disease.
    Iba M; Kwon S; Kim C; Szabo M; Horan-Portelance L; Lopez-Ocasio M; Dagur P; Overk C; Rissman RA; Masliah E
    J Neuroinflammation; 2024 Apr; 21(1):93. PubMed ID: 38622654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson's disease.
    Williams GP; Schonhoff AM; Jurkuvenaite A; Thome AD; Standaert DG; Harms AS
    J Neuroinflammation; 2018 Aug; 15(1):244. PubMed ID: 30165873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of cannabinoid receptor 2 promotes α-Synuclein-induced microglial synaptic pruning in nucleus accumbens by modulating the pCREB-c-Fos signaling pathway and complement system.
    Feng L; Lo H; You H; Wu W; Cheng X; Xin J; Ye Z; Chen X; Pan X
    Exp Neurol; 2023 Jan; 359():114230. PubMed ID: 36162511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microglia as modulators of exosomal alpha-synuclein transmission.
    Xia Y; Zhang G; Han C; Ma K; Guo X; Wan F; Kou L; Yin S; Liu L; Huang J; Xiong N; Wang T
    Cell Death Dis; 2019 Feb; 10(3):174. PubMed ID: 30787269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GV-971 attenuates α-Synuclein aggregation and related pathology.
    Yu Z; Yang Y; Chan RB; Shi M; Stewart T; Huang Y; Liu Z; Lan G; Sheng L; Tian C; Yang D; Zhang J
    CNS Neurosci Ther; 2024 Feb; 30(2):e14393. PubMed ID: 37563872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clearance and deposition of extracellular alpha-synuclein aggregates in microglia.
    Lee HJ; Suk JE; Bae EJ; Lee SJ
    Biochem Biophys Res Commun; 2008 Aug; 372(3):423-8. PubMed ID: 18492487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson's disease.
    Reyes JF; Ekmark-Léwen S; Perdiki M; Klingstedt T; Hoffmann A; Wiechec E; Nilsson P; Nilsson KPR; Alafuzoff I; Ingelsson M; Hallbeck M
    Acta Neuropathol Commun; 2021 Mar; 9(1):46. PubMed ID: 33743820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TLR2 Potentiates SR-Marco-Mediated Neuroinflammation by Interacting with the SRCR Domain.
    Wang L; Yang HY; Zang CX; Shang JM; Liu H; Zhang ZH; Yuan FY; Ju C; Li FY; Bao XQ; Zhang D
    Mol Neurobiol; 2021 Nov; 58(11):5743-5755. PubMed ID: 34398403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Interplay between α-Synuclein and Microglia in α-Synucleinopathies.
    Deyell JS; Sriparna M; Ying M; Mao X
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.